28 September 2026
Semax vs N-Acetyl Semax Amidate: Checking the 3-4x Claim
Is N-Acetyl Semax Amidate really 3-4x stronger than Semax? We check the research, the PGP metabolite question and Semax's legal status in Australia.
Peptides · Cognitive & Mood
Semax
ACTH(4-7)PGP
Approved in Russia · unapproved in the West
A synthetic fragment of the hormone ACTH developed in Soviet-era Russia, used there for decades as a stroke and cognitive treatment — yet virtually untested in Western-standard randomised trials.
At a glance
- Decades of clinical use in Russia for stroke and cognition
- Appears to raise BDNF in preclinical studies
- Almost no Western-standard randomised trial evidence
- Unapproved in Australia, the US and Europe
How it works
Semax appears to raise BDNF (a key neuroplasticity factor) and modulate brain neurotransmitter systems. Proposed effects include neuroprotection and enhanced attention and memory, largely based on Russian clinical experience and animal work.
What the research shows
Russian trials — many small, unblinded or published only in Russian — report benefits in stroke recovery and cognitive performance. No Semax trial has ever been registered on ClinicalTrials.gov, and the most recent Russian clinical publication dates to 2018; independent Western replication is essentially nonexistent.
Regulatory status
Australia
Semax has no entry in the Poisons Standard — but that doesn't make it legal to use. It is not on the ARTG, so importing or supplying it for therapeutic use makes it an unapproved therapeutic good under the Therapeutic Goods Act, and unapproved peptide products are a current TGA enforcement priority.
Worldwide
A registered medicine in Russia (as nasal drops) and on Russia's Vital and Essential Drugs list. Not approved by the FDA, EMA or TGA — though in 2026 a US compounding advisory committee voted narrowly to recommend it for the compounding bulks list, against FDA staff advice; that vote is advisory only.
Latest Semax articles
25 September 2026
Semax Research: The 80-Mouse Alzheimer's Model Test
A December 2025 study tested Semax in 80 Alzheimer's model mice. What it found, why APP/PS1 plaque data is weak evidence, and Semax's Australian legal status.
23 September 2026
Semax Australia: The FDA Compounding Vote Changes Nothing
In July 2026 an FDA panel backed Semax for US compounding, against its own reviewers. What that vote means, and whether Semax is legal in Australia.
20 September 2026
Semax Research: The New Targets That Aren't BDNF
Two 2025 Semax papers moved past BDNF: a mu-opioid receptor target in mice and an Alzheimer's model result. What the evidence shows, plus Semax Australia rules.
17 September 2026
Semax Dosing Research: The Trials Ran on Milligrams
Semax dosing research: human studies used 16 mcg/kg and 6,000 mcg/day, far above typical microdoses. What the evidence shows, plus Semax's Australian status.
14 September 2026
N-Acetyl Semax Amidate vs Semax: What Capping Changes
Is Semax legal in Australia, and does N-Acetyl Semax Amidate beat plain Semax? What the capping does, what one in vitro study found, and the TGA status.
12 September 2026
Semax Research: The Healthy-Brain Evidence Gap
Semax research is concentrated in stroke and optic-nerve patients, not healthy brains. What the human data shows, the dose gap, and is Semax legal in Australia.
9 September 2026
Semax and the FDA Compounding Vote: What It Means for Australia
An FDA panel backed Semax for US compounding in July 2026. What is Semax, is Semax legal in Australia, and what does the research actually show?
This is general information, not medical advice. retatrutide.net.au is an independent publication. Unless stated otherwise above, this compound is not an approved medicine in Australia, and this page does not endorse or facilitate its use. Speak to a registered health practitioner about any treatment decision.
Stay informed
Be first to know.
When it reaches Australia.
Retatrutide is not yet available to the public. But when it is, you will want to be first to know. Sign up to receive:
- The latest clinical trial results and news from Eli Lilly
- Updates on TGA regulatory progress in Australia
- How and where to access Retatrutide when it becomes available
- Occasional information from retatrutide.net.au and our affiliated partners
TGA review expected 2027 — subscribers hear the moment the status changes.
Get the free guide + updates
Enter your details once on our free access guide page — instant download, plus we'll email you the moment there's real news.